Miyoshi Muscular Dystrophy 1, also known as miyoshi myopathy, is related to muscular dystrophy, becker type and kidney cancer, and has symptoms including decreased grip strength An important gene associated with Miyoshi Muscular Dystrophy 1 is DYSF (Dysferlin), and among its related pathways/superpathways are miRNA role in immune response in sepsis and miRNAs involved in DNA damage response. The drugs Deflazacort and Immunosuppressive Agents have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle and heart, and related phenotypes are proximal muscle weakness in lower limbs and pelvic girdle muscle weakness